Recalls / Class II
Class IID-1081-2017
Product
Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial per Carton, 100 vials per case. Hospira, Inc., Lake Forest, IL 60045 USA, NDC: 0409-2634-50
- Brand name
- Hydromorphone Hydrochloride
- Generic name
- Hydromorphone Hydrochloride
- Active ingredient
- Hydromorphone Hydrochloride
- Route
- Intramuscular, Intravenous, Subcutaneous
- NDC
- 0409-2634
- FDA application
- ANDA078591
- Affected lot / code info
- Lot #: 56260DD, Exp. 01AUG2017
Why it was recalled
Presence of Particulate Matter: Silicone oil
Recalling firm
- Firm
- HOSPIRA INC, LAKE FOREST
- Manufacturer
- Hospira, Inc.
- Notification channel
- Telephone
- Type
- Voluntary: Firm initiated
- Address
- 275 NORTH FOREST DRIVE, N/A, LAKE FOREST, Illinois 60045
Distribution
- Quantity
- 9,009 vials
- Distribution pattern
- Nationwide in the USA
Timeline
- Recall initiated
- 2017-07-26
- FDA classified
- 2017-08-09
- Posted by FDA
- 2017-08-16
- Terminated
- 2018-05-11
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1081-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.